Hexagon Bio snags $47m Series A

Menlo Park, California-based Hexagon Bio Inc, a biotechnology company turning nature's genomes into medicines, has raised $47 million in Series A financing.

Menlo Park, California-based Hexagon Bio Inc, a biotechnology company turning nature’s genomes into medicines, has raised $47 million in Series A financing. The Column Group led the round with participation from 8VC and Two Sigma Ventures.

Source: Press Release